Clinical trialNCT01617629CompletedPhase 2Interventional

Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study

SponsorPrima BioMed LtdEnrollment9Epithelial Ovarian Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this trial is to assess the safety profile of Cvac for epithelial ovarian cancer patients who were enrolled in the Cvac clinical trial CAN-003 and are no longer eligible for study participation due to disease progression.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Fernando Recio, MD
Collaborative Research Group
Principal Investigator
clinicaltrials.gov ↗
Giuseppe Del Priore, MD
Indiana University
Principal Investigator
clinicaltrials.gov ↗
Heidy Gray, MD
University of Washington
Principal Investigator
clinicaltrials.gov ↗
James Mason, MD
Scripps Cancer Center
Principal Investigator
clinicaltrials.gov ↗
Jeffery Goh, MBBS, FRACP
Greenslopes Private Hospital
Principal Investigator
clinicaltrials.gov ↗
Peter Eisenberg, MD
Marin Cancer Care
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Greenslopes Private Hospital
Greenslopes, Queensland, Australia

United States

Marin Cancer Care, Inc.
Greenbrae, California, United States
Scripps Cancer Center
La Jolla, California, United States
Collaborative Research Group
Boca Raton, Florida, United States
Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
University of Washington Medical Center
Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MUC1 Dendritic Cell Vaccine

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2011
Primary completion: 30 Apr 2014
Completion: 30 Apr 2014
Last update posted: 8 Dec 2017
Registered enrollment: 9
Registry id: NCT01617629

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.